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Clostridium difficile Colitis After Aortic Surgery 
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Objective: To determine the incidence and outcome of Clostridium difficile colitis (CDC) following aortic surgery. 
Design: Retrospective clinical study, and case-note r view. 
Patients: Of 180 patients undergoing aortic surgery for either aneurysmal or occlusive disease between 1 September 
1994 and 31 August 1996 (24 months), 15 (8.4%) developed CDC. There were 12 male and three female patients of 
median age 65 (range 46-84). 
Results: Two patients died from multiple organ failure in association with CDC, one of whom underwent negative re- 
laparotomy for suspected ischaemic bowel because the diagnosis of CDC had not been entertained. Previously identified 
risk factors for CDC comprised: age >65 (eight); renal impairment (four); chronic obstructive airways disease (seven); 
coexistent malignancy (three); admission from another hospital (four); Ha antagonist therapy (13); ITU (nine); and~or 
HDU care (14). Diarrhoea commenced a median of 9 (range 5-26) days, and CDC, was diagnosed a median of 14 (range 
10-26) days after operation. All patients received intravenous Cefuroxime, originally prescribed as prophylaxis, for a 
median of 6 (range 3-16) days prior to onset of CDC. Two patients received 1 additional ntibiotic; one received 2; two 
received 3; and one received 4 prior to onset of CDC. 
Conclusions: CDC is a common and potentially serious complication ofvascular, and in particular, aortic surgery. 
Although such patients often possess several risk factors for CDC, colitis frequently follows prolonged 'prophylactic' 
cephalosporin administration, which should therefore be avoided. 
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Introduction 
Over the last 10 years there has been a marked increase 
in the number of surgical patients developing symp- 
tomatic Clostridium difficile (CD) infection. 1 This is due 
to several factors: heightened awareness of the con- 
dition; better methods of diagnosis; more widespread 
use of antibiotics for treatment and prophylaxis; and 
the increasing numbers of elderly and immuno- 
compromised patients with malignancy, sepsis, and 
(multi) organ failure being cared for within intensive 
therapy (ITU) and high dependency units (HDU). 2 In 
addition to morbidity and mortality, the economic 
burden of CD infection in terms of delayed discharge 
is considerable. Although elderly patients with peri- 
pheral vascular disease undergoing aortic surgery are 
* Correspondence should be addressed to: Mr. A. W. Bradbury, 
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EH3 9YW. 
likely to be at increased risk of CD colitis (CD) for a 
variety of reasons, this has not been previously studied. 
The aim of this paper, therefore, was to review the 
incidence, diagnosis, treatment, and clinical sig- 
nificance of CDC in patients undergoing aortic surgery 
for aneurysmal or occlusive disease. 
Patients and Methods 
Patients with CDC were identified by interrogating a 
prospectively completed atabase of all patients test- 
ing positive for CD toxin within the department of 
microbiology. Patients undergoing aortic surgery were 
identified from a prospectively completed vascular 
surgery unit database. Case notes of patients under- 
going aortic surgery who developed clinically ap- 
parent, CD toxin-positive diarrhoea during the same 
admission were then reviewed. Between 1 September 
1994 and 31 August 1996, 180 patients underwent 
aortic surgery for occlusive or aneurysmal disease. 
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Table 1. CDC in patients undergoing aortic surgery. 
Day of event related to day of Median (days) Range (days) 
admission (day 1) 
Aortic operation 3 1-11 
Commencement of diarrhoea 9 5-26 
Diagnosis of CDC 14 10-26 
Treatment for CDC commenced 14 11-32 
Delay between events in days  Median (days) Range (days) 
Aortic operation and onset of 6 4-19 
diarrhoea 
Onset of diarrhoea and 1 0-9 
diagnosis of CDC 
Onset of diarrhoea and 2 1-9 
treatment 
Commencement of treatment 5 1-11 
and cessation ofdiarrhoea (or 
death) 
Unit policy stipulated that patients undergoing aortic 
surgery should receive prophylactic Cefuroxime 
750rag (Glaxo UK, Greenford, Middx., U.K.) intra- 
venously thrice daily and Ranitidine 50 mg (Glaxo UK, 
Greenford, Middx., U.K.) intravenously twice daily 
for 5 days postoperatively. 
Clinical consequences ofCDC 
Two patients died from multiple organ failure (MOF) 
in association with CDC, one of whom underwent 
negative re-laparotomy for suspected ischaemic bowel 
because the diagnosis of CDC had not been en- 
tertained. This patient had been operated on for rup- 
tured abdominal aortic aneurysm and on the third 
postoperative day was making an uneventful recovery 
when he developed abdominal distension, pain, and 
profuse diarrhoea. On examination the patient was 
dehydrated and exhibited lower abdominal ten- 
derness. Investigation revealed a leukocytosis and a 
metabolic acidosis; plain abdominal radiograph 
showed distended loops of bowel. A provisional diag- 
nosis of ischaemic bowel was made and the patient 
taken to theatre. At laparotomy, the small and large 
bowel were diffusely distended and oedematous but 
there was no evidence of ischaemic or other intra- 
abdominal pathology and no surgical procedure was 
undertaken. Forty-eight hours later the stool tested 
positive for CD toxin and the patient was commenced 
on vancomycin via nasogastric tube. 
Results 
Patients with CDC 
Of 180 patients undergoing aortic surgery between 1
September 1994 and 31 August 1996, 15 (8.3%) de- 
veloped clinically significant, toxin-positive CDC. 
There were 12 male and three female patients of 
median age 65 (range 46-84). There was no significant 
difference in the incidence of CDC between those 
operated for occlusive (2/45) and those operated for 
aneurysmal disease (13/135, p=0.52, Fisher's exact 
test). Despite a reduction in CDC in the hospital as a 
whole over the period of the study, there has been a 
significant increase in the proportion of patients with 
CDC who had undergone a vascular surgical pro- 
cedure. Thus, between 1 September 1994 and 31 Aug- 
ust 1995 there were six vascular patients (three aortic 
procedures) out of a total of 271 patients with CD- 
positive stool samples (2.2%) compared to 16 (12 aortic 
procedures) out of 217 CD-positive patients (7.4%) 
between i September 1995 and 31 August 1996 (p<0.05, 
Fisher's exact est). Patients were operated on a median 
of 3 (range 1-11) days after admission. The timing of 
onset of diarrhoea, diagnosis and commencement of 
treatment in relation to the day of operation is shown 
in Table 1. 
Antibiotic exposure prior to onset of CDC 
All patients had received Cefuroxime 750 mg intra- 
venously thrice daily. In all cases this had orginally 
been prescribed as prophylaxis to cover insertion of a 
prosthetic aortic graft and potential infection arising 
from central venous cannulae in the early post- 
operative period. Unit policy stipulated that this anti- 
biotic should be prescribed for 5 postoperative days 
and then discontinued. However, patients with CDC 
had received this 'prophylactic' antibiotic for a median 
of 6 (range 3-16) days prior to onset of diarrhoea. In 
most cases the antibiotic had been continued without 
any microbiological evidence of infection sensitive 
to Cefuroxime. Eight patients received one antibiotic 
(Cefuroxime) only, while the other patients had re- 
ceived multiple antibiotics prior to the onset of diar- 
rhoea (Table 2). 
Risk factors of CDC 
The majority of patients possessed several previously 
identified risk factors for CDC, 2 including age >65 
(n =8); renal impairment (n =4); chronic obstructive 
airways disease (n =7); coexistent malignancy (n=3); 
admission from another hospital (n = 4); H2 antagonist 
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Table 2. Antibiotic exposure prior to the development of CDC and treatment administered. 
Patient *Day of *Day Antibiotic exposure Treatment 
operation symptoms (drug, route, and days) (drug and days) 
commenced 
1 1 11 Cefuroxime, IV, 1-8 Metronidazole, NG, 26-27 
Benzyl penicillin, IV, 1-25 
Metronidazole, IV 1-25 
Ceftazidime, IV, 6-25 
Clarithromycin, IV 13-25 
Vancomycin, IV, 2145 
2 1 11 Cefuroxime, IV, 1-12 Vancomycin, O 14-17 
Metronidazole, IV 1 -20  Metronidazole, O, 19-50 
Ceftazidime, IV, 20-25 
Clarithromycin, IV 13-21 
3 5 9 Cefuroxime, IV, 2-11 Metronidazole, O 14-18 
4 7 26 Cefuroxime, IV, 6-10 Vancomychl, O 32--44 
Metronidazole, IV 7-10, 14-17 Metronidazole, O, 45-53 
Ceftazidime, IV, 14-17 
5 4 10 Cefuroxime, IV, 4-12 Metronidazole, O 12-15 
6 11 16 Cefuroxime, IV, ]1-16 Withdrawal of antibiotic 
Metronidazole, IV 4-12 
7 9 21 Cefuroxime, IV, 9-23 Metronidazole, O 23-26 
Vancomycin, IV, 14-21 
8 3 9 Cefuroxime, IV, 3-7 Withdrawal of antibiotic 
9 2 12 Cefuroxime, IV, 2-10 Withdrawal of antibiotic 
10 1 5 Cefuroxime, IV, l-3 Vancomycin, O 22-32 
Metronidazole, IV 1-32 
Vancomycin, IV, 14-51 
11 3 9 Cefuroxime, IV, 3-8 Metronidazole, O 11-25 
12 1 6 Cefuroxime, IV, 1-6 Withdrawal of antibiotic 
13 3 9 Cefuroxime, IV, 3-9 Metronidazole, IV 11-14 
14 7 12 Cefuroxime, IV, 7-11 Withdrawal of antibiotic 
15 7 13 Cefuroxime, IV, 7-14 Metronidazole, O 15-24 
Erythromycin, IV 9-15 
Amoxicillin, IV, 9-15 
Vancomycin, IV, 14-22 
* Day l is taken as the day of admission to our hospital; IV =intravenous; O =oral; NG =nasogastric tube 
administration. 
therapy (n=13); ITU care (n=9) and/or  HDU care 
(n = 14). 
Treatment of CDC 
Five patients were treated by withdrawal of antibiotic 
only. These patients had mild disease and all were 
receiving Cefuroxime only at the time diarrhoea com- 
menced. The remaining patients were treated with 
either Metronidazole or Vancomycin (Table 2). 
Conclusions 
CD infection may be a trivial and self-limiting con- 
dition in otherwise healthy persons undergoing anti- 
biotic therapy for minor infection. However, in patients 
undergoing major surgery, CDC is an important cause 
of morbidity and a significant contributor to mortality. 3 
Although virtually every field of surgery appears af- 
fected by this nosocomial disease, patients undergoing 
vascular operations have not previously been spe- 
cifically studied. 4 Many studies examining the ef- 
fectiveness of broad spectrum cephalosporins as 
prophylaxis describe an association with CD-related 
postoperative diarrhoea. 5 Even when only one to three 
doses of antibiotic are given, the risk of CD infection 
is apparent, and increases markedly when therapy is 
continued in to the postoperative period, 6 an ob- 
servation that is confirmed by the present study. 
Patients on prolonged, combination antimicrobial ther- 
apy are at greatest risk. Diagnosis of CDC may be a 
particular problem following aortic surgery, because 
diarrhoea is often thought o represent colonic isch- 
aemia rather than infection. While ischaemia usually 
manifests itself within 48h of surgery, the present 
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study indicates that diarrhoea due to CDC nearly 
always has a later onset. Prompt diagnosis and treat- 
ment of CD infection in surgical patients is crucial if 
morbidity and mortality are to be minimised. 7 For 
example, in a recent series of 201 patients with CD 
colitis, the overall mortality was 3.5%. Surgical inter- 
vention was required in 5% of cases and was associated 
with a mortality of 30%. The only discriminative factor 
in this large study between patients who died and 
those who survived was length of time from symptoms 
to treatment - 6 days for survivors vs. nearly 11 days 
for those who died. 1 In a series of 710 mixed medical 
and surgical patients, factors that significantly pre- 
disposed to the development of severe CD colitis 
included malignancy, chronic obstructive airways dis- 
ease, immunosuppressive and antiperistaltic med- 
ications, and renal failure. STwenty-one (3%) of these 
patients required admission to ITU or died as a result 
of their CD infection. In a series of over 200 surgical 
patients who developed CDC, 9 diarrhoea developed 
on average 10 days postoperatively and patients had 
received an average of three to four different antibiotics 
before the diagnosis was made. The overall mortality 
was 8%. Five patients (2%) developed toxic dilatation, 
of whom four died. Twenty-five per cent of all deaths 
were thought o be directly attributable to the effects 
of CD infection. Six variables were identified as pre- 
dictive of increased mortality rate: administration of 
laxatives and steroids, length of preoperative stay in 
hospital, postoperative interval before onset of symp- 
toms, use of total parenteral as opposed to enteral 
nutrition, and abdominal distension. Lipsett and col- 
leagues reviewed all adult patients undergoing sur- 
gical intervention for CD-related infection over a 6- 
year period. 1° In that time 37 000 CD toxin assays had 
been performed, of which 3300 were positive. Thirteen 
adults (0.39% of all affected patients) required surgical 
intervention for their CD infection, of whom 38% died. 
It is important to remember that the first pre- 
sentation of CD infection may be as a surgical emer- 
gency with a clinical picture more commonly 
associated with fulminant ischaemic or ulcerative col- 
itis; namely toxic dilatation and perforation. H Patients 
presenting in this way may undergo emergency lap- 
arotomy to their detriment before the true diagnosis 
is established, as in the case of our patient who was 
incorrectly diagnosed as having ishaemic olitis. 
In summary, CD colitis is a common and potentially 
serious nosocomial infection following aortic surgery. 
Although many of the affected patients were on mul- 
tiple antibiotics and had several other risk factors, in 
the majority of cases CDC follows prolonged ce- 
phalosporin therapy which has originally been pre- 
scribed as prophylaxis. It was also evident hat prior 
treatment with intravenous Metronidazole or van- 
comycin (usually prescribed for Methicillin-resistant 
Staphylococcus aureus) did not prevent he onset of CD 
colitis. In addition to morbidity, CDC contributed to 
the death of two patients. CDC should be considered 
high in the differential in any patient developing diar- 
rhoea after major vascular surgery. 12 
This study has prompted us to change the pro- 
phylacitc antibiotic strategy in patients undergoing 
aortic surgery. Patients now receive only three doses 
of Cefuroxime 750 mg 8-hourly, and two doses of 
Vancomycin i g, adjusted to take into account renal 
function, 12-hourly postoperatively. Prolonged courses 
of postoperative c phalosporin treatment are avoided 
and every attempt is made to base continuing antibiotic 
therapy upon microbiological evidence of infection 
and sensitivity testing. 
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